Thursday, 21 February, 2019

Analyst's Ratings : AbbVie Inc. (NYSE:ABBV)

Melissa Porter | 08 February, 2018, 08:06

The stock increased 2.63% or $2.925 during the last trading session, reaching $114.125. Shares for $1.66 million were sold by Gosebruch Henry O. Another trade for 8,300 shares valued at $705,655 was sold by SALEKI-GERHARDT AZITA. Analysts are turning out to be more optimistic than before, with 10 of analysts who cover AbbVie Inc. It has underperformed by 8.92% the S&P500.

Alex Sacerdote decreased its stake in Netease Inc (NTES) by 1.13% based on its latest 2017Q3 regulatory filing with the SEC. The institutional investor owned 34,983 shares of the company's stock after acquiring an additional 1,442 shares during the quarter. The stock price mounted 20.46% in three months and soared 56.14% for the last six months trading period. Capital Research Global Investors bought 10.74M shares as the company's stock rose 6.17% with the market. It has outperformed by 40.63% the S&P500.

Investors sentiment increased to 1.14 in 2017 Q3. The company reported $1.48 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.44 by $0.04. It improved, as 42 investors sold HON shares while 453 reduced holdings. Paragon Cap Management holds 0.35% or 10,248 shares. Provident Trust holds 0.06% or 15,978 shares in its portfolio. Garrison Bradford & Associates holds 2,330 shares or 0.33% of its portfolio. Regal Inv Advisors Ltd Liability Corp has 27,237 shares. If we consider a median price to earnings ratio on the stock, that corresponds with a stock price of 13.22. Godsey & Gibb Assocs reported 133,077 shares stake. Nokota Management Limited Partnership invested in 251,250 shares. Ca reported 228,583 shares stake. Arete Wealth Llc reported 0.36% stake. Guardian Life Com Of America holds 0.04% of its portfolio in Honeywell International Inc. William Blair analyst Y. Xu now expects that the company will post earnings of $1.80 per share for the quarter, up from their prior forecast of $1.50. Vision Management Inc reported 1.32% in Facebook, Inc.

Since September 11, 2017, it had 0 insider buys, and 5 insider sales for $25.59 million activity. Greatmark Investment Partners Inc. now owns 35,178 shares of the company's stock valued at $2,551,000 after purchasing an additional 1,242 shares during the period. $1.66M worth of AbbVie Inc. (NASDAQ:FB) was sold by Stretch Colin on Tuesday, September 5. Also, EVP Michael Severino sold 25,633 shares of the business's stock in a transaction that occurred on Friday, November 10th.

In related news, SVP Timothy J. Richmond sold 87,040 shares of the company's stock in a transaction on Monday, December 18th. Another trade for 15,470 shares valued at $2.59 million was made by Wehner David M. on Monday, August 21. It also reduced its holding in Amphenol Corporation Com (NYSE:APH) by 4,117 shares in the quarter, leaving it with 14,091 shares, and cut its stake in S&P Mid (IJJ).

Among 18 analysts covering NetEase (NASDAQ:NTES), 11 have Buy rating, 4 Sell and 3 Hold. Therefore 95% are positive. Facebook had 236 analyst reports since July 21, 2015 according to SRatingsIntel. The company was maintained on Wednesday, October 7 by UBS. The stock of Honeywell International Inc. SunTrust Banks boosted their price target on AbbVie to $157.00 and gave the stock an "average" rating in a research report on Monday, January 29th. Credit Suisse downgraded AbbVie Inc. The rating was upgraded by CLSA to "Buy" on Wednesday, January 4. The rating was maintained by FBN Securities on Tuesday, September 26 with "Buy". As per Friday, June 23, the company rating was maintained by Jefferies. The firm has "Buy" rating by Goldman Sachs given on Thursday, July 27. Goldman Sachs maintained Facebook, Inc. The rating was initiated by Brean Capital with "Buy" on Monday, July 18.

Investors sentiment decreased to 1.34 in Q3 2017. Its down 0.14, from 0.94 in 2017Q2. It dropped, as 55 investors sold ABBV shares while 640 reduced holdings. 73 funds opened positions while 295 raised stakes. Lazard Asset Management Limited Liability Com invested in 0.09% or 486,734 shares.

This company shares (ABBV) so far managed to recover 85.18% since collapsing to its 52-week low. AbbVie has a fifty-two week low of $60.05 and a fifty-two week high of $125.86. $589,512 worth of AbbVie Inc. Finally, AMG National Trust Bank lifted its position in shares of AbbVie by 1.0% during the 3rd quarter. Annex Advisory Services LLC lifted its position in shares of AbbVie by 17.7% during the 3rd quarter. Hilton Cap Mgmt Lc invested in 0.07% or 4,660 shares. Blue Edge Ltd Liability Corp has invested 0.11% in AbbVie Inc. (NYSE:ABBV). Kidder Stephen W has 37,723 shares for 1.24% of their portfolio. (NYSE:HON). The Alabama-based Associated Banc has invested 0.65% in Honeywell International Inc. (NYSE:ABBV) for 148,802 shares. (NASDAQ:PEP). State Of Alaska Department Of Revenue stated it has 0.94% in Pepsico, Inc. (NYSE:ABBV) or 6,950 shares. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating, nine have issued a buy rating and one has given a strong buy rating to the stock. Therefore 38% are positive. AbbVie makes up about 1.9% of Hayek Kallen Investment Management's portfolio, making the stock its 26th largest holding. The firm has "Equal-Weight" rating by Morgan Stanley given on Tuesday, January 30. Engineers Gate Manager LP invested 0.15% of its portfolio in, inc. Goldman Sachs maintained the stock with "Buy" rating in Friday, March 10 report. (NYSE:ABBV) on Monday, November 28 to "Neutral" rating. The rating was upgraded by Leerink Swann to "Outperform" on Monday, October 2. Finally, Zacks Investment Research lowered shares of AbbVie from a "buy" rating to a "hold" rating in a research report on Monday, January 22nd.